Biocartis (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- January 15, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founding Year
- 2007
- Traction
- Biocartis has established partnerships with major healthcare organizations and has seen significant growth in the adoption of its diagnostic solutions.
- Revenue Amount
- $10,000,000
- ARR
- $5,000,000
- Organizations Involved
- Major healthcare organizations and diagnostic labs.
- Founders
- Eddy De Geyter, Herman Verrelst
- Company Description
- Biocartis is a molecular diagnostics company that develops and commercializes innovative diagnostic solutions for personalized medicine. Their technology enables rapid and reliable testing for various diseases, including cancer, using a unique platform that integrates sample preparation and analysis.
- Market
- Healthcare Diagnostics
- Location
- Mechelen, Belgium
- Coinvestors
- Investors include leading venture capital firms and strategic partners.